ahuebner@guardanthealth.com

September 16, 2024

An Open Letter from AmirAli Talasaz, co-CEO of Guardant Health

To Our Patients, Healthcare Providers, Partners, and Employees, At Guardant Health, we are committed to bringing innovative and accurate cancer diagnostic tools

Guardant signage outside company headquarters
June 11, 2024

FDA Advisory Committee Strongly Recommends Approval For Guardant Health Blood Test For Colorectal Cancer

Panel recommends approval of Shield as primary non-invasive screening option in adults aged 45 and older at average risk for the disease